AI assistant
Panacea Biotec Ltd. — Regulatory Filings 2021
Dec 31, 2021
62573_rns_2021-12-31_f883226b-767b-4c2c-b226-519b4201fda1.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [142 x 65] intentionally omitted <==
December 31, 2021
The Manager, Listing Department The National Stock Exchange of India Ltd. Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 NSE Symbol : PANACEABIO
BSE Limited Corporate Relationship Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 BSE Scrip Code: 531349
Sub: Intimation of Closure of Trading Window
Dear Sir/Madam,
Pursuant to the Company’s Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform that the trading window of the Company shall remain closed for all the Designated Persons of the Company from January 01, 2022 till completion of 48 hours from the announcement to the Stock Exchanges regarding Unaudited financial results of the Company for the quarter and nine months ended December 31, 2021.
The date of meeting of the Board of Directors to approve the Unaudited financial results of the Company for the quarter and nine months ended December 31, 2021, shall be informed in due course.
This is for your kind information and record please.
Thanking you,
Sincerely yours,
For Panacea Biotec Ltd.
==> picture [66 x 32] intentionally omitted <==
Vinod Goel Group CFO and Head Legal & Company Secretary
Panacea Biotec Ltd (CIN: L33117PB1984PLC022350) Regd. Office : Ambala Chandigarh Higway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn../G-3, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Fax: 91-11-4167 9070 Email: [email protected]